DK0822935T3 - Fremgangsmåde til fremstilling af rene enantiomerer af tropasyreestere - Google Patents

Fremgangsmåde til fremstilling af rene enantiomerer af tropasyreestere

Info

Publication number
DK0822935T3
DK0822935T3 DK96919644T DK96919644T DK0822935T3 DK 0822935 T3 DK0822935 T3 DK 0822935T3 DK 96919644 T DK96919644 T DK 96919644T DK 96919644 T DK96919644 T DK 96919644T DK 0822935 T3 DK0822935 T3 DK 0822935T3
Authority
DK
Denmark
Prior art keywords
preparation
acid esters
pure enantiomers
tropic acid
tropic
Prior art date
Application number
DK96919644T
Other languages
Danish (da)
English (en)
Inventor
Rolf Banholzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7760581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0822935(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0822935T3 publication Critical patent/DK0822935T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK96919644T 1995-04-28 1996-04-29 Fremgangsmåde til fremstilling af rene enantiomerer af tropasyreestere DK0822935T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19515625A DE19515625C2 (de) 1995-04-28 1995-04-28 Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
PCT/EP1996/001779 WO1996033996A1 (de) 1995-04-28 1996-04-29 Verfahren zur herstellung von enantiomerenreinen tropasäureestern

Publications (1)

Publication Number Publication Date
DK0822935T3 true DK0822935T3 (da) 2001-12-27

Family

ID=7760581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919644T DK0822935T3 (da) 1995-04-28 1996-04-29 Fremgangsmåde til fremstilling af rene enantiomerer af tropasyreestere

Country Status (26)

Country Link
US (1) US5952505A (cs)
EP (1) EP0822935B1 (cs)
JP (1) JP3988056B2 (cs)
KR (1) KR100386383B1 (cs)
CN (1) CN1050357C (cs)
AT (1) ATE208389T1 (cs)
AU (1) AU702141B2 (cs)
BG (1) BG62209B1 (cs)
BR (1) BR9608288A (cs)
CZ (1) CZ292579B6 (cs)
DE (2) DE19515625C2 (cs)
DK (1) DK0822935T3 (cs)
EE (1) EE03398B1 (cs)
ES (1) ES2167573T3 (cs)
HU (1) HU228037B1 (cs)
MX (1) MX9708211A (cs)
NO (1) NO316175B1 (cs)
NZ (1) NZ308462A (cs)
PL (1) PL183118B1 (cs)
PT (1) PT822935E (cs)
RO (1) RO118871B1 (cs)
RU (1) RU2162850C2 (cs)
SK (1) SK283793B6 (cs)
TR (1) TR199701266T1 (cs)
TW (1) TW413680B (cs)
WO (1) WO1996033996A1 (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2279345A1 (en) 1997-01-31 1998-08-06 Human Genome Sciences, Inc. Tissue factor pathway inhibitor-3
KR20020093083A (ko) * 2000-04-27 2002-12-12 베링거 잉겔하임 파르마 카게 신규한 완효성 베타모사체, 이의 제조방법 및 약제로서의이의 용도
ME00245B (me) * 2000-10-12 2011-02-10 Boehringer Ingelheim Int Novi tiotropijumski preparati-koji sadrže prah za in haliranje
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US6852728B2 (en) 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10212264A1 (de) * 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
RU2004132222A (ru) * 2002-04-04 2005-10-10 Берингер Ингельхайм Фарма Гмбх Унд Ко.Кг (De) Порошковые композиции, пригодные для ингаляции
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
CN102473567A (zh) * 2010-02-12 2012-05-23 松下电器产业株式会社 等离子显示面板的制造方法
US9113862B2 (en) 2010-09-30 2015-08-25 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with a variable staple forming system
CN103387534B (zh) * 2012-05-09 2015-02-18 北大方正集团有限公司 一种拆分托吡卡胺外消旋体的方法
CN104628718A (zh) * 2014-06-11 2015-05-20 苏州景泓生物技术有限公司 一种合成东莨菪碱及其盐的方法
CN114080473B (zh) 2019-08-08 2025-09-19 巴斯夫欧洲公司 用于抑制钨蚀刻的组合物
CN115572290B (zh) * 2022-09-06 2024-11-26 河北仁合益康药业有限公司 一种一锅法合成异丙托溴铵的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1289429A (fr) * 1960-03-10 1962-04-06 Lepetit Spa Procédé de préparation des nouveaux esters de la tropine
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof

Also Published As

Publication number Publication date
NO316175B1 (no) 2003-12-22
RU2162850C2 (ru) 2001-02-10
JPH11504027A (ja) 1999-04-06
BR9608288A (pt) 1999-06-29
HUP9802210A2 (hu) 1999-02-01
HK1010878A1 (en) 1999-07-02
TW413680B (en) 2000-12-01
PT822935E (pt) 2002-04-29
KR19990008072A (ko) 1999-01-25
TR199701266T1 (xx) 1998-02-21
PL323038A1 (en) 1998-03-02
BG101948A (en) 1998-05-29
US5952505A (en) 1999-09-14
MX9708211A (es) 1997-12-31
RO118871B1 (ro) 2003-12-30
EP0822935A1 (de) 1998-02-11
DE59608148D1 (de) 2001-12-13
NZ308462A (en) 1999-01-28
DE19515625A1 (de) 1996-10-31
HU228037B1 (en) 2012-08-28
PL183118B1 (pl) 2002-05-31
NO974967D0 (no) 1997-10-27
CN1050357C (zh) 2000-03-15
EE03398B1 (et) 2001-04-16
EP0822935B1 (de) 2001-11-07
ES2167573T3 (es) 2002-05-16
JP3988056B2 (ja) 2007-10-10
SK283793B6 (sk) 2004-01-08
WO1996033996A1 (de) 1996-10-31
EE9700262A (et) 1998-06-15
ATE208389T1 (de) 2001-11-15
AU5812096A (en) 1996-11-18
CN1183098A (zh) 1998-05-27
AU702141B2 (en) 1999-02-11
SK144497A3 (en) 1998-03-04
DE19515625C2 (de) 1998-02-19
CZ292579B6 (cs) 2003-10-15
HUP9802210A3 (en) 2000-03-28
NO974967L (no) 1997-10-27
KR100386383B1 (ko) 2003-09-19
BG62209B1 (bg) 1999-05-31
CZ340597A3 (cs) 1998-01-14

Similar Documents

Publication Publication Date Title
DK0822935T3 (da) Fremgangsmåde til fremstilling af rene enantiomerer af tropasyreestere
DK0877090T3 (da) Fremgangsmåde til produktion af L-aminosyrer
DK0672670T3 (da) Fremgangsmåde til fremstilling af clavulansyre
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DK0754756T3 (da) Fremgangsmåde til fremstilling af L-lysin
DE69614174D1 (de) Verfahren zur Herstellung von optisch-aktiven Gamma-substituierte-Hydroxy-Buttersäure-Ester
DK0897970T3 (da) Fremgangsmåde til fremstilling af stanolestere
DK89294A (da) Fremgangsmåde til krystallisation af iodamidol
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0889873T3 (da) Fremgangsmåde til fremstilling af alkoxylerede fedtsyrealkylestere
DK0607795T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-4-fluormethylthiazolcarboxylsyrealkylestere
IS4636A (is) Aðferð við framleiðslu á hreinum enantíómerum af asetidín-2-karboxýlsýru
DK0786012T3 (da) Enzymatisk fremgangsmåde til fremstilling af kiral-alfa-tertiære carboxylsyreestere
DK0906255T3 (da) Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre
FI955328A7 (fi) Menetelmä formyylikarboksyylihappoestereiden valmistamiseksi
FI942581A7 (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
DE59602149D1 (de) Verfahren zur Herstellung von 2-Fluor-isobuttersäure-alkylestern
DK0648748T3 (da) Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2
DE59602784D1 (de) Verfahren zur Herstellung von Alkylestern der (Meth)acrylsäure
DK0782982T3 (da) Fremgangsmåde til fremstilling af o-chlormethyl-phenylglyoxylsyrederivater
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
DK0717046T3 (da) Fremgangsmåde til fremstilling af phosphonsyrederivater
DK0931052T3 (da) Fremgangsmåde til fremstilling af dinitratestere
DK0729959T3 (da) Fremgangsmåde til fremstilling af loracarbefmonohydrat